Page last updated: 2024-08-24

simendan and Intraventricular Septal Defects

simendan has been researched along with Intraventricular Septal Defects in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Behera, SK; Chowdhury, SR; Das, M; Nag, P; Narayan, P1
Castellheim, A; Keski-Nisula, J; Ricksten, SE; Romlin, BS; Suominen, PK; Synnergren, M; Thorlacius, EM; Vistnes, M; Wåhlander, H1

Trials

2 trial(s) available for simendan and Intraventricular Septal Defects

ArticleYear
Levosimendan or Milrinone for Ventricular Septal Defect Repair With Pulmonary Arterial Hypertension.
    Journal of cardiothoracic and vascular anesthesia, 2023, Volume: 37, Issue:6

    Topics: Cardiotonic Agents; Child; Heart Septal Defects, Ventricular; Heart Ventricles; Humans; Hydrazones; Milrinone; Prospective Studies; Pulmonary Arterial Hypertension; Pyridazines; Simendan

2023
The Effect of Levosimendan Versus Milrinone on the Occurrence Rate of Acute Kidney Injury Following Congenital Heart Surgery in Infants: A Randomized Clinical Trial.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2019, Volume: 20, Issue:10

    Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Creatinine; Double-Blind Method; Female; Finland; Heart Defects, Congenital; Heart Septal Defects; Heart Septal Defects, Ventricular; Humans; Infant; Male; Milrinone; Prospective Studies; Simendan; Sweden; Tetralogy of Fallot

2019